PDE5A and COVID-19: In a response to high demand for PDE5 inhibitors in the medical field, researchers have been repurposing existing PDE5 inhibitors and developing new structurally related scaffolds for more effective incorporation of PDE5 inhibitors into medical practice, especially in case of recent global health concerns, such as COVID-19.